Novartis India Ltd.

672.25

-17.1 (-2.5%)growUp

NOVARTIND Share Price
As on October 25, 2023
Sector
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap1,566 Cr
P/E Ratio16.44
Dividend Yield0.74 %
Trendline Performance

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open691.05
High698.2
NSE SymbolNOVARTIND
Close672.25
Low668.35
BSE Symbol500672
Previous Years High/Low
1 Year HighN/A
3 Year High909
5 Year High1,098
1 Year LowN/A
3 Year Low537
5 Year Low530.05

Technicals


IndicatorsValueSignal
5-DMA698.72Bearish
10-DMA706.82Bearish
20-DMA712.51Bearish
50-DMA721.98Bearish
100-DMA756.87Bearish
200-DMA690.01Bearish

Historical Performance


1 Year
N/A
3 Years
8.3%
5 Years
3.7%
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a moderate PE of 16.44, suggesting fair valuation relative to earnings.
  • Over the last three years, the stock delivered price CAGR data is unavailable.
  • The stock carries beta data is unavailable, making volatility assessment inconclusive.
  • In the last financial year, the company reported an EBITDA of ₹1334 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹3563 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹
Current Value: ₹
No. of Shares: NaN (Approx)
Performance:%
P/L: ₹
NIFTY Performance: %
1 day Top Gainers
SymbolChange%
TEJASNET339.05(15%)
DATAPATTNS2610.6(14%)
HINDCOPPER633.4(13%)
OLECTRA1088.4(10%)
SCHNEIDER697.7(10%)
1 Day Top Losers
SymbolChange%
RADICO2746.8(-6%)
HOMEFIRST1190.9(-5%)
TATACONSUM1131.8(-5%)
ASIANPAINT2511.8(-4%)
VMM119.86(-4%)
BERGEPAINT478.85(-3%)
EMCURE1435.8(-3%)
AIIL502.1(-3%)

Top Performing Stocks from the same sector


Mangalam Drugs And Organics Ltd.

68.6%

40.1

1 Month Performance

NGL Fine-Chem Ltd.

29.3%

1710.5

1 Month Performance

Ind-Swift Laboratories Ltd.

18.8%

108.7

1 Month Performance

Acutaas Chemicals Ltd.

12.7%

1862.4

1 Month Performance

Zim Laboratories Ltd.

9%

74.77

1 Month Performance

Torrent Pharmaceuticals Ltd.

3.7%

3958.7

1 Month Performance

Alkem Laboratories Ltd.

3.4%

5722.5

1 Month Performance

Alivus Life Sciences Ltd.

2.8%

932.7

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month